Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trigeminal neuralgia: current treatments and future developments.

Andrew Fisher1, Joanna M Zakrzewska, Philip N Patsalos

  • 1Pharmacology and Therapeutics Unit, Department of Clinical and Experimental Epilepsy, Institute of Neurology, Queen Square, London WC1N 3BG, UK.

Expert Opinion on Emerging Drugs
|November 13, 2003
PubMed
Summary

Trigeminal neuralgia patients need better pain relief. This review explores current and emerging drug treatments for trigeminal neuralgia (TN) to improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Qualitative validation of TnED©, an electronic instrument capturing pain dimensions in patients with trigeminal neuralgia.

Journal of oral & facial pain and headache·2026
Same author

Ex-situ machine perfusion across the organs; shared principles and transferable knowledge from clinical trials.

Transplantation reviews (Orlando, Fla.)·2026
Same author

Encountering pain: images as a tool for collaborative approaches to pain medicine.

Pain·2026
Same author

A non-AI preliminary algorithm for the prediction and detection of highly pathogenic African swine fever in pigs using health monitoring collars.

Animal welfare (South Mimms, England)·2026
Same author

In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment.

Cell reports·2026
Same author

Management of persistent idiopathic facial pain (PIFP) - An international Delphi study.

Cephalalgia : an international journal of headache·2025

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Trigeminal neuralgia (TN) causes severe facial pain, often refractory to existing treatments.
  • Current pharmacotherapy provides inadequate relief for a significant number of TN patients.
  • Drug side effects at therapeutic doses limit treatment options.

Purpose of the Study:

  • To review current pharmacotherapies for trigeminal neuralgia.
  • To highlight emerging drug treatments for trigeminal neuralgia.
  • To enhance treatment options for patients with trigeminal neuralgia.

Main Methods:

  • Literature review of current and emerging pharmacotherapies for trigeminal neuralgia.
  • Analysis of treatment efficacy and side effect profiles.
  • Synthesis of findings to inform future therapeutic strategies.

Related Experiment Videos

Main Results:

  • Current drug treatments offer partial relief for many, but a substantial unmet need persists.
  • Drug resistance and adverse effects necessitate alternative or novel therapeutic approaches.
  • Emerging drug candidates show promise for improved trigeminal neuralgia management.

Conclusions:

  • There is a critical need for novel antineuralgic drugs for trigeminal neuralgia.
  • Advancements in pharmacotherapy are essential to improve the quality of life for TN patients.
  • This review provides insights into current and future pharmacological interventions for trigeminal neuralgia.